Universal Vision Biotechnology Co., Ltd. (TPEX: 3218)

Universal Vision Biotechnology Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 9, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	18,428	23,469	23,859	21,543	18,193	5,138
Market Cap Growth	-37.62%	-1.63%	10.75%	18.41%	254.07%	168.39%
Enterprise Value	17,969	23,062	23,751	21,599	18,004	5,131
Last Close Price	217.50	269.51	269.41	238.72	198.74	54.66
PE Ratio	16.77	21.89	26.89	34.01	34.89	19.50
PS Ratio	4.42	5.75	6.83	8.19	8.86	3.62
PB Ratio	5.87	7.02	8.43	9.25	8.92	3.03
P/FCF Ratio	16.44	21.71	30.65	36.68	34.20	27.93
P/OCF Ratio	13.70	15.11	18.81	23.63	22.00	12.26
EV/Sales Ratio	4.31	5.65	6.80	8.21	8.77	3.62
EV/EBITDA Ratio	9.83	14.49	18.34	22.91	24.33	13.77
EV/EBIT Ratio	13.27	17.58	21.97	28.10	30.18	20.77
EV/FCF Ratio	16.03	21.33	30.51	36.77	33.85	27.89
Debt / Equity Ratio	0.26	0.23	0.28	0.33	0.30	0.34
Debt / EBITDA Ratio	0.47	0.44	0.54	0.71	0.72	1.19
Debt / FCF Ratio	0.77	0.72	1.01	1.31	1.15	3.17
Asset Turnover	0.83	0.85	0.85	0.76	0.71	0.60
Inventory Turnover	5.95	6.26	7.89	11.17	12.71	9.95
Quick Ratio	2.16	2.18	2.05	2.17	1.98	2.09
Current Ratio	2.53	2.52	2.37	2.43	2.18	2.32
Return on Equity (ROE)	35.64%	34.48%	33.66%	27.96%	25.93%	11.60%
Return on Assets (ROA)	16.86%	17.02%	16.37%	13.88%	12.82%	6.51%
Return on Capital (ROIC)	21.61%	21.20%	20.14%	16.71%	15.12%	7.64%
Earnings Yield	5.96%	4.45%	3.56%	2.76%	2.66%	4.63%
FCF Yield	6.08%	4.61%	3.26%	2.73%	2.92%	3.58%
Dividend Yield	3.22%	2.60%	2.10%	1.88%	1.90%	3.29%
Payout Ratio	97.41%	45.89%	44.75%	53.70%	31.51%	39.98%
Buyback Yield / Dilution	-0.08%	-0.04%	-0.03%	0.04%	0.10%	0.12%
Total Shareholder Return	3.14%	2.55%	2.07%	1.92%	2.00%	3.41%

Source: S&P Capital IQ. Standard template. Financial Sources.